Publications

Publications

Conference
Maeda H, Toizumi M, Igarashi A, Maeda M, Oda F, Fukuda H.
Incidence of COVID-19 Hospitalization and Seizures by Vaccination in Youth in Japan: VENUS Study.
The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, Nagasaki January 28-30, 2026.
Zha L, Kimura Y, Komatsu M, Shimomura Y, Gon Y, Maeda M, Oda F, Komukai S, Kiyohara K, Kitamura T, Fukuda H.
Association of PPSV23 with Parkinson’s and Alzheimer’s Disease Risk: The VENUS Study.
The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, NagasakiJanuary 28-30, 2026.
Sung Y, Goto K, Maeda M, Oda F, Fukuda H.
Bias in vaccination coverage from incomplete in-migrant records in Japan: the VENUS Study.
The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, Nagasaki January 28-30, 2026.
Nishimura S, Kumamaru T, Maeda M, Oda F, Fukuda H.
Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Older Adults : the VENUS Study.
ISPE's 17th Asian Conference on Pharmacoepidemiology (ACPE 2025) 21-23 November 2025. Hong Kong, China.
三村亘, 石黒智恵子, 前田恵, 小田太史, 福田治久.
日本脳炎ワクチン接種率と限定出荷の影響の評価: VENUS Study.
第84回日本公衆衛生学会総会. 2025年10月29日~10月31日. 静岡.
福田治久.
自治体が実施する任意接種ワクチンの独自助成の実施状況.
第29回日本ワクチン学会/第66回日本臨床ウイルス学会合同学術集会. 2025年9月27日~28日.札幌.
Uemura Y, Shinozaki T, Shimizu Y, Mimura W, Fukuda H, Ishiguro C.
Safety Evaluation of Multiple Vaccination Regimens for the Elderly in Japan: The VENUS Study.
2025 ISPE Annual Meeting. Washington DC, USA.22-26 August 2025.
Morita H, Ishiguro C, Mimura W, Tsuzuki S, Terada-Hirashima J, Takeuchi Y, Maeda M, Fukuda H.
Assessment of the Safety of Human Papillomavirus Vaccination in Japan: VENUS Study.
2025 ISPE Annual Meeting. Washington DC, USA.22-26 August 2025.
Ishiguro C, Shinozaki T, Kumamaru H, Fukuda H, Mimura W, Shimizu Y, Uemura Y.
Developing the Framework of Epidemiological and Biostatistical Approaches for Post-Approval Vaccine Safety Assessment Using a Large Healthcare Database in Japan: Year 1 Progress.
2025 ISPE Annual Meeting. Washington DC, USA. 22-26 August 2025.
三村亘, 石黒智恵子, 清水陽介, 寺田純子, 前田恵, 村田典子, 福田治久
Target trial emulationによる高齢者インフルエンザワクチンの接種タイミングの評価: VENUS Study.
第35回日本疫学会学術総会2025年2月12日~14日. 高知
1 2 3 4 5 6